Cellular activation in the immune response of sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 35, Issue 3, 2014, Pages 307-315

  Zissel, Gernot ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

antigen presentation; granuloma; immunoregulation; macrophages; sarcoid antigens; sarcoidosis; T lymphocytes

Indexed keywords

AUTOANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; MKATG ANTIGEN; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG; ANTIGEN; CHEMOKINE; CYTOKINE;

ARTICLE; CELLULAR IMMUNITY; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; GRANULOMA; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOREGULATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REGULATORY T LYMPHOCYTE; SARCOIDOSIS; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; LYMPHOCYTE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIGENS; CHEMOKINES; CYTOKINES; GRANULOMA; HUMANS; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; SARCOIDOSIS; T-LYMPHOCYTES;

EID: 84904507189     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0034-1376861     Document Type: Article

References (108)

1. Spagnolo P., Grunewald J. Recent advances in the genetics of sarcoidosis. J Med Genet: 2013; 50 5 290 297
2. Müller-Quernheim J., Schürmann M., Hofmann S., et al. Genetics of sarcoidosis. Clin Chest Med: 2008; 29 3 391 414, viii (Pubitemid 351778209)
3. Iannuzzi M. C., Maliarik M. J., Poisson L. M., Rybicki B. A. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med: 2003; 167 9 1225 1231 (Pubitemid 36555094)
4. Rybicki B. A., Maliarik M. J., Poisson L. M., et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med: 2003; 167 3 444 449 (Pubitemid 36216430)
5. Grunewald J., Janson C. H., Eklund A., et al. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol: 1992; 22 1 129 135
6. Oswald-Richter K., Sato H., Hajizadeh R., et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB11101. J Clin Immunol: 2010; 30 1 157 166
7. Nguyen T., Liu X. K., Zhang Y., Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol: 2006; 176 12 7354 7360 (Pubitemid 43849036)
8. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet: 2005; 37 4 357 364
9. Zissel G., Ernst M., Schlaak M., Müller-Quernheim J. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med: 1997; 45 2 75 86 (Pubitemid 127453340)
10. Adrianto I., Lin C. P., Hale J. J., et al. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS ONE: 2012; 7 8 e43907
11. Li Y., Wollnik B., Pabst S., et al. BTNL2 gene variant and sarcoidosis. Thorax: 2006; 61 3 273 274
12. Rybicki B. A., Walewski J. L., Maliarik M. J., Kian H., Iannuzzi M. C.; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet: 2005; 77 3 491 499 (Pubitemid 41192655)
13. Ishihara M., Ohno S., Ishida T., et al. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue Antigens: 1995; 46 1 59 62
14. Seitzer U., Swider C., Stüber F., et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine: 1997; 9 10 787 790 (Pubitemid 27477724)
15. Feng Y., Zhou J., Gu C., et al. Association of six well-characterized polymorphisms in TNF-α and TNF-β genes with sarcoidosis: a meta-analysis. PLoS ONE: 2013; 8 11 e80150
16. Somoskövi A., Zissel G., Seitzer U., Gerdes J., Schlaak M., Müller-Quernheim J. Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine: 1999; 11 11 882 887 (Pubitemid 29537538)
17. Vasakova M., Sterclova M., Kolesar L., et al. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Respir Med: 2009; 103 5 773 779
18. Zissel G., Homolka J., Schlaak J., Schlaak M., Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med: 1996; 154 3 Pt 1 713 719 (Pubitemid 26327296)
19. Krein P. M., Winston B. W. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. Chest: 2002; 122 (6, Suppl): 289S 293S (Pubitemid 36043015)
20. Sgonc R., Wick G. Pro- and anti-fibrotic effects of TGF-beta in scleroderma. Rheumatology (Oxford): 2008; 47 05 v5 v7
21. Prud'homme G. J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest: 2007; 87 11 1077 1091
22. Muraközy G., Gaede K. I., Zissel G., Schlaak M., Müller-Quernheim J. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-beta 1 in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 2001; 18 2 165 169 (Pubitemid 32601534)
23. Gaede K. I., Amicosante M., Schürmann M., Fireman E., Saltini C., Müller-Quernheim J. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. J Mol Med (Berl): 2005; 83 5 397 405 (Pubitemid 41201804)
24. Kruit A., Grutters J. C., Ruven H. J., et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest: 2006; 129 6 1584 1591 (Pubitemid 43894990)
25. Pabst S., Fränken T., Schönau J., et al. Transforming growth factor-beta gene polymorphisms in different phenotypes of sarcoidosis. Eur Respir J: 2011; 38 1 169 175
26. Crouser E. D., Julian M. W., Crawford M., et al. Differential expression of microRNA and predicted targets in pulmonary sarcoidosis. Biochem Biophys Res Commun: 2012; 417 2 886 891
27. Pabst S., Baumgarten G., Stremmel A., et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol: 2006; 143 3 420 426
28. Pabst S., Bradler O., Gillissen A., Nickenig G., Skowasch D., Grohe C. Toll-like receptor-9 polymorphisms in sarcoidosis and chronic obstructive pulmonary disease. Adv Exp Med Biol: 2013; 756 239 245
29. Veltkamp M., van Moorsel C. H., Rijkers G. T., Ruven H. J., Grutters J. C. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens: 2012; 79 1 25 32
30. Veltkamp M., Grutters J. C., van Moorsel C. H., Ruven H. J., van den Bosch J. M. Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin Exp Immunol: 2006; 145 2 215 218 (Pubitemid 44060110)
31. Agostini C., Meneghin A., Semenzato G. T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med: 2002; 8 5 435 440 (Pubitemid 34836949)
32. Nicod L. P., Cochand L., Dreher D. Antigen presentation in the lung: dendritic cells and macrophages. Sarcoidosis Vasc Diffuse Lung Dis: 2000; 17 3 246 255
33. Agerberth B., Grunewald J., Castaños-Velez E., et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med: 1999; 160 1 283 290 (Pubitemid 29326101)
34. Zissel G., Bäumer I., Fleischer B., Schlaak M., Müller- Quernheim J. TCR V beta families in T cell clones from sarcoid lung parenchyma, BAL, and blood. Am J Respir Crit Care Med: 1997; 156 5 1593 1600 (Pubitemid 27505530)
35. Darlington P., Haugom-Olsen H., von Sivers K., et al. T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis-indication for an airborne antigen as the triggering factor in sarcoidosis. J Intern Med: 2012; 272 5 465 471
36. Crowley L. E., Herbert R., Moline J. M., et al. Sarcoid like granulomatous pulmonary disease in World Trade Center disaster responders. Am J Ind Med: 2011; 54 3 175 184
37. Izbicki G., Chavko R., Banauch G. I., et al. World Trade Center sarcoid-like granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest: 2007; 131 5 1414 1423 (Pubitemid 46762347)
38. Jordan H. T., Stellman S. D., Prezant D., Teirstein A., Osahan S. S., Cone J. E. Sarcoidosis diagnosed after September 11, 2001, among adults exposed to the World Trade Center disaster. J Occup Environ Med: 2011; 53 9 966 974
39. Kveim A. M. the date is OK, page numbers are 169-172. Nord Med: 1941; 9 169 172
40. e Conf intern: 1967; 150 153
41. Mitchell D. N. The nature and physical characteristics of a transmissible agent from human sarcoid tissue. Ann N Y Acad Sci: 1976; 278 233 248
42. Mitchell D. N., Rees R. J., Goswami K. K. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet: 1976; 2 7989 761 765
43. Mitchell D. N. Mycobacteria and sarcoidosis. Lancet: 1996; 348 9030 768 769 (Pubitemid 26308476)
44. Moller D. R. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc: 2007; 4 5 465 468 (Pubitemid 47435374)
45. Maertzdorf J., Weiner J. III, Mollenkopf H. J., et al. TBornotTB Network. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A: 2012; 109 20 7853 7858
46. Abe C., Iwai K., Mikami R., Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg [A]: 1984; 256 4 541 547 (Pubitemid 14116052)
47. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol: 2002; 40 1 198 204 (Pubitemid 34027624)
48. Wahlström J., Dengjel J., Persson B., et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest: 2007; 117 11 3576 3582 (Pubitemid 350097012)
49. Wahlström J., Dengjel J., Winqvist O., et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol: 2009; 133 3 353 363
50. Müller-Quernheim J., Gaede K. I., Fireman E., Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J: 2006; 27 6 1190 1195 (Pubitemid 44914303)
51. Zissel G., Prasse A., Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med: 2010; 31 4 390 403
52. Bianchi M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol: 2007; 81 1 1 5 (Pubitemid 46028489)
53. Pechkovsky D. V., Zalutskaya O. M., Ivanov G. I., Misuno N. I. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol: 2000; 29 1 27 33
54. Korthagen N. M., Nagtegaal M. M., van Moorsel C. H., Kazemier K. M., van den Bosch J. M., Grutters J. C. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Clin Exp Immunol: 2010; 161 2 342 347
55. Bargagli E., Olivieri C., Prasse A., et al. Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation: 2008; 31 5 351 354
56. Veress B., Malmsköld K. The distribution of S100 and lysozyme immunoreactive cells in the various phases of granuloma development in sarcoidosis. Sarcoidosis: 1987; 4 1 33 37
57. Riva M., Källberg E., Bjork P., et al. Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent. Immunology: 2012; 137 2 172 182
58. Yonekawa K., Neidhart M., Altwegg L. A., et al. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis: 2011; 218 2 486 492
59. Ashitani J., Matsumoto N., Nakazato M. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis. Respirology: 2007; 12 3 339 345 (Pubitemid 47164772)
60. Biragyn A., Ruffini P. A., Leifer C. A., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science: 2002; 298 5595 1025 1029 (Pubitemid 35247310)
61. Paone G., Lucantoni G., Leone A., et al. Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis. Chest: 2009; 135 2 586 587
62. Chen E. S., Song Z., Willett M. H., et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med: 2010; 181 4 360 373
63. Oswald-Richter K. A., Culver D. A., Hawkins C., et al. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun: 2009; 77 9 3740 3748
64. Pathak S. K., Basu S., Basu K. K., et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol: 2007; 8 6 610 618 (Pubitemid 46785125)
65. Murphy E. E., Terres G., Macatonia S. E., et al. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med: 1994; 180 1 223 231 (Pubitemid 24181071)
66. Gabrilovich M. I., Walrath J., van Lunteren J., et al. Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol: 2013; 173 3 512 522
67. Wikén M., Grunewald J., Eklund A., Wahlström J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol: 2009; 29 1 78 89
68. Wikén M., Idali F., Al Hayja M. A., Grunewald J., Eklund A., Wahlström J. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir Res: 2010; 11 121
69. Veltkamp M., Wijnen P. A., van Moorsel C. H., et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol: 2007; 149 3 453 462 (Pubitemid 47256146)
70. Hogan L. H., Heninger E., Elsner R. A., et al. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation. Int Immunol: 2007; 19 5 627 633 (Pubitemid 47072206)
71. Du Bois R. M., Kirby M., Balbi B., Saltini C., Crystal R. G. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis: 1992; 145 5 1205 1211
72. Müller-Quernheim J., Saltini C., Sondermeyer P., Crystal R. G. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J Immunol: 1986; 137 11 3475 3483 (Pubitemid 17193303)
73. Devergne O., Emilie D., Peuchmaur M., Crevon M. C., D'Agay M. F., Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes. Hum Pathol: 1992; 23 3 317 323
74. Richmond B. W., Ploetze K., Isom J., et al. Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression. J Clin Immunol: 2013; 33 2 446 455
75. Facco M., Cabrelle A., Teramo A., et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax: 2011; 66 2 144 150
76. Furusawa H., Suzuki Y., Miyazaki Y., Inase N., Eishi Y. Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis. Respir Investig: 2012; 50 3 104 109
77. Ten Berge B., Paats M. S., Bergen I. M., et al. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford): 2012; 51 1 37 46
78. Bianco A., Spiteri M. A. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox or birds of a feather. Clin Exp Immunol: 1997; 110 1 1 3 (Pubitemid 27428506)
79. Hudspith B. N., Brostoff J., McNicol M. W., Johnson N. M. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response. Clin Exp Immunol: 1984; 57 2 324 330 (Pubitemid 14089379)
80. Bansal A. S., Bruce J., Hogan P. G., Allen R. K. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23. Clin Exp Immunol: 1997; 110 1 92 97 (Pubitemid 27428520)
81. Mathew S., Bauer K. L., Fischoeder A., Bhardwaj N., Oliver S. J. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol: 2008; 181 1 746 755
82. Oswald-Richter K. A., Richmond B. W., Braun N. A., et al. Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol: 2013; 190 11 5446 5453
83. Miyara M., Amoura Z., Parizot C., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med: 2006; 203 2 359 370 (Pubitemid 43290845)
84. Lee N. S., Barber L., Kanchwala A., et al. Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol: 2011; 18 2 223 234
85. Mroz R. M., Korniluk M., Stasiak-Barmuta A., Ossolinska M., Chyczewska E. Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosis. Eur J Med Res: 2009; 14 04 165 169
86. Wikén M., Grunewald J., Eklund A., Wahlström J. Multiparameter phenotyping of T-cell subsets in distinct subgroups of patients with pulmonary sarcoidosis. J Intern Med: 2012; 271 1 90 103
87. Rappl G., Pabst S., Riemann D., et al. Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin Immunol: 2011; 140 1 71 83
88. Taflin C., Miyara M., Nochy D., et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol: 2009; 174 2 497 508
89. Fehrenbach H., Zissel G., Goldmann T., et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J: 2003; 21 3 421 428 (Pubitemid 36336199)
90. Wallis R. S., Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum: 2005; 34 5 01 34 38
91. Baughman R. P., Drent M., Kavuru M., et al. Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med: 2006; 174 7 795 802 (Pubitemid 44511661)
92. Idali F., Wahlström J., Müller-Suur C., Eklund A., Grunewald J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol: 2008; 152 1 127 137 (Pubitemid 351347561)
93. Liu G., Ma H., Qiu L., et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol Cell Biol: 2011; 89 1 130 142
94. Tiemessen M. M., Jagger A. L., Evans H. G., van Herwijnen M. J., John S., Taams L. S. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A: 2007; 104 49 19446 19451
95. Prasse A., Pechkovsky D. V., Toews G. B., et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med: 2006; 173 7 781 792
96. Pechkovsky D. V., Prasse A., Kollert F., et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol: 2010; 137 1 89 101
97. Cai M., Bonella F., He X., et al. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Respir Med: 2013; 107 9 1444 1452
98. Julian M. W., Shao G., Schlesinger L. S., et al. Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest: 2013; 143 2 461 470
99. Valeyre D., Soler P., Clerici C., et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax: 1988; 43 7 516 524
100. Hattori T., Konno S., Shijubo N., Ohmichi M., Nishimura M. Increased prevalence of cigarette smoking in Japanese patients with sarcoidosis. Respirology: 2013; 18 7 1152 1157
101. Gupta D., Singh A. D., Agarwal R., Aggarwal A. N., Joshi K., Jindal S. K. Is tobacco smoking protective for sarcoidosis? A case-control study from North India. Sarcoidosis Vasc Diffuse Lung Dis: 2010; 27 1 19 26
102. Delgado M., Gomariz R. P., Martinez C., Abad C., Leceta J. Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock. Eur J Immunol: 2000; 30 11 3236 3246
103. Delgado M., Ganea D. Vasoactive intestinal peptide inhibits IL-8 production in human monocytes. Biochem Biophys Res Commun: 2003; 301 4 825 832 (Pubitemid 36279188)
104. Prasse A., Zissel G., Lützen N., et al. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am J Respir Crit Care Med: 2010; 182 4 540 548
105. Lyons D. J., Donald S., Mitchell D. N., Asherson G. L. Chemical inactivation of the Kveim reagent. Respiration: 1992; 59 1 22 26
106. Roberts S. D., Wilkes D. S., Burgett R. A., Knox K. S. Refractory sarcoidosis responding to infliximab. Chest: 2003; 124 5 2028 2031 (Pubitemid 37433610)
107. Okamoto Yoshida Y., Umemura M., Yahagi A., et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol: 2010; 184 8 4414 4422
108. Zhang Y., Chen L., Gao W., et al. IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice. Eur J Immunol: 2012; 42 6 1523 1535